EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

Session comprising selected EuroPCR 2022 Late-Breaking Trial submissions

Facilitators: P. Lemos, P. Smits

Discussants: R. Byrne, M. C. Morice, C. Lotan, D. Moliterno

Summary

Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and efficacy of robotic-assisted PCI using R-One device, andThe ROLEX (Revascularisation Of LEft main with resolute onyX) study.

Presentations available when logged in:

Five-year follow-up in the SORT OUT VIII trial
Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
The ROLEX (Revascularisation Of LEft main with resolute onyX) study
Impact of side branch disease pattern on outcome following left main PCI
Safety and efficacy of robotic-assisted PCI using R-One device
FANTOM II trial: safety and performance study, final five-year clinical outcomes

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

Session comprising selected EuroPCR 2022 Late-Breaking Trial submissions

Log in or create account for free